Inicio › Mieloma múltiple › Nueva York › Queens
Ensayos clínicos de Mieloma múltiple en Queens, NY
20 estudios para Mieloma múltiple buscan participantes en centros de Queens y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
ReclutandoFase 3
- Northwell Health Cancer Institute, Lake Success · A 9 mi de distancia
- NYU Langone Hospital Long Island, Mineola · A 11 mi de distancia
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
ReclutandoFase 3
- MSK Nassau, Uniondale · A 13 mi de distancia
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 3
- NYU Winthrop, Mineola · A 11 mi de distancia
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ReclutandoFase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · A 11 mi de distancia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
ReclutandoFase 2
- Queens Cancer Center, Rego Park · A 3 mi de distancia
- Cohen Children's Medical Center, New Hyde Park · A 9 mi de distancia
- Northwell Health Monter Cancer Center, Lake Success · A 9 mi de distancia
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
ReclutandoFase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · A 13 mi de distancia
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
ReclutandoFase 3
- Long Island Jewish Medical Center, New Hyde Park · A 9 mi de distancia
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · A 9 mi de distancia
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
ReclutandoFase 3
- MSK Nassau, Uniondale · A 13 mi de distancia
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
ReclutandoFase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
ReclutandoFase 3
- Research Site, New Hyde Park · A 9 mi de distancia
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
ReclutandoEstudio observacional
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · A 10 mi de distancia
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
ReclutandoFase 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
ReclutandoFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
ReclutandoFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
ReclutandoFase 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · A 11 mi de distancia
A Dietary Study for People With Multiple Myeloma
Reclutando
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
ReclutandoFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
ReclutandoFase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · A 13 mi de distancia
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Memorial Sloan Kettering Rockville, Rockville Centre · A 10 mi de distancia
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Reclutando
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · A 13 mi de distancia
Más información sobre Mieloma múltiple en MedlinePlus
Ensayos de Mieloma múltiple en otras ciudades
- New York City, NY60 estudios
- Boston, MA42 estudios
- Atlanta, GA41 estudios
- Houston, TX38 estudios
- Durham, NC37 estudios
- Nashville, TN32 estudios
- Denver, CO26 estudios
- Rochester, MN24 estudios
- Columbus, OH24 estudios
- Baldwin Park, CA23 estudios
- St. Louis, MO23 estudios
- Chicago, IL22 estudios
Otros estudios en Queens
- Cáncer de seno63 estudios
- Cáncer de pulmón de células no pequeñas49 estudios
- Cáncer del colon y del recto31 estudios
- Cáncer metastásico28 estudios
- Cáncer de ovario28 estudios
- Cáncer de próstata27 estudios
- Cáncer de endometrio26 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de pulmón22 estudios
- Leucemia mielógena aguda21 estudios
- Cáncer de páncreas20 estudios
- Carcinoma de células escamosas de cabeza y cuello20 estudios
De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.